Regenxbio (RGNX) Gross Margin Growth (5y) (2019 - 2025)

Regenxbio (RGNX) Gross Margin Growth (5y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Regenxbio 528.62 Mn 298.55 Mn 21.22 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2,599.00
Sep 30, 2025 -170.00
Jun 30, 2025 389.00
Mar 31, 2025 1,537.00
Dec 31, 2024 243.00
Sep 30, 2024 -3,423.00
Jun 30, 2024 -2,397.00
Mar 31, 2024 -2,463.00
Dec 31, 2023 -4,362.00
Sep 30, 2023 -3,310.00
Jun 30, 2023 -3,776.00
Mar 31, 2023 -1,967.00
Dec 31, 2022 -2,206.00
Sep 30, 2022 173.00
Jun 30, 2022 -1,960.00
Mar 31, 2022 -5,074.00
Dec 31, 2021 -596.00
Sep 30, 2021 -2,824.00
Jun 30, 2021 -4,250.00
Mar 31, 2021 -1,805.00